Aly Jackson

Aly Jackson is a Business Development Leader at Genentech/Roche. In this role, she leads diligence efforts and strategic deal discussions with potential partners to advance collaborations in drug discovery and development. Her primary focus is on platform partnerships that drive innovation in areas such as drug delivery, small molecule therapeutics, and target discovery. Prior to her current role, Aly held various positions within Genentech’s Pharma Technical organization, most recently serving as a Human Factors Engineer in Device Development. She holds Bachelor’s and Master’s degrees in Bioengineering from UCLA, and an MBA from the UC Berkeley Haas School of Business.